26 May 2020 argenx announces positive topline results from Phase 3 ADAPT Trial of Efgartigimod in patients with Generalized Myasthenia Gravis Member news
21 May 2020 Gilead and Galapagos announce positive topline results of Phase 2B/3 trial of Filgotinib Member news
18 May 2020 Bone Therapeutics treats first patients in pivotal JTA-004 phase III knee osteoarthritis study Member news
08 May 2020 Progressing clinical development of next generation therapies for Diabetic eye disease – beyond anti-VEGF Member news
06 May 2020 Biotalys’ first biocontrol proves consistent, high efficacy in global fruit and vegetables field trial program Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
